- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic adenine base editing of human hematopoietic stem cells
Authors
Keywords
-
Journal
Nature Communications
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-13
DOI
10.1038/s41467-022-35508-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia
- (2022) Bin Fu et al. NATURE MEDICINE
- Base editing of haematopoietic stem cells rescues sickle cell disease in mice
- (2021) Gregory A. Newby et al. NATURE
- Reactivation of γ-globin expression through Cas9 or base editor to treat β-hemoglobinopathies
- (2020) Liren Wang et al. CELL RESEARCH
- Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
- (2020) Jordan L. Doman et al. NATURE BIOTECHNOLOGY
- Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
- (2020) Leslie Weber et al. Science Advances
- Directed evolution of adenine base editors with increased activity and therapeutic application
- (2020) Nicole M. Gaudelli et al. NATURE BIOTECHNOLOGY
- Author Correction: Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
- (2020) Michelle F. Richter et al. NATURE BIOTECHNOLOGY
- Cas9 activates the p53 pathway and selects for p53-inactivating mutations
- (2020) Oana M. Enache et al. NATURE GENETICS
- Therapeutic base editing of human hematopoietic stem cells
- (2020) Jing Zeng et al. NATURE MEDICINE
- Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
- (2020) Russell T. Walton et al. SCIENCE
- Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System
- (2020) Yuning Song et al. Molecular Therapy-Nucleic Acids
- Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
- (2020) Michael V. Zuccaro et al. CELL
- Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
- (2020) Erica B. Esrick et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
- (2020) Haydar Frangoul et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos
- (2019) Erwei Zuo et al. SCIENCE
- Highly efficient therapeutic gene editing of human hematopoietic stem cells
- (2019) Yuxuan Wu et al. NATURE MEDICINE
- CRISPResso2 provides accurate and rapid genome editing sequence analysis
- (2019) Kendell Clement et al. NATURE BIOTECHNOLOGY
- Genome-wide target specificity of CRISPR RNA-guided adenine base editors
- (2019) Daesik Kim et al. NATURE BIOTECHNOLOGY
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- Switching from fetal to adult hemoglobin
- (2018) Xunde Wang et al. NATURE GENETICS
- Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
- (2018) Gabriella E. Martyn et al. NATURE GENETICS
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- Hi-TOM: a platform for high-throughput tracking of mutations induced by CRISPR/Cas systems
- (2018) Qing Liu et al. Science China-Life Sciences
- Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies
- (2018) Beeke Wienert et al. TRENDS IN GENETICS
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Gene Therapy in a Patient with Sickle Cell Disease
- (2017) Jean-Antoine Ribeil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan province of Southwestern China
- (2017) Jie Zhang et al. BMJ Open
- Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
- (2016) Guillaume Lettre et al. LANCET
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution
- (2016) M Ryan Corces et al. NATURE GENETICS
- Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
- (2016) T. Masuda et al. SCIENCE
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
- (2014) S. Bae et al. BIOINFORMATICS
- An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
- (2013) D. E. Bauer et al. SCIENCE
- Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of -thalassemia
- (2008) M. Uda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
- (2008) G. Lettre et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now